In contrast, we found that the HMGCR‐dependent gene signature reported in this work has some prognostic value for breast cancer patients according to specific clinical features (distant recurrence‐free survival for nonstratified patients and for chemotherapy‐insensitive patients). Here, HMGCR is linked to breast cancer.